You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cutaneous T-Cell Lymphoma (CTLC)

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer, BRAF V600 Mutation, Melanoma Trial (XP-102, Trametinib)

Not yet recruiting
  • Cancer
  • +5 more
  • (no location specified)
Aug 18, 2022

Head Neck Cancer, Head and Neck Squamous Cell Carcinoma Trial in Worldwide (Evorpacept, Pembrolizumab)

Recruiting
  • Head and Neck Cancer
  • Head and Neck Squamous Cell Carcinoma
  • Irvine, California
  • +10 more
Nov 4, 2021

Abnormal Respiratory Cell Populations in Lung Cancer Screening

Not yet recruiting
  • Lung Cancer
    • (no location specified)
    May 12, 2023

    COPD (COPD) Trial (Benralizumab, Benralizumab , Comparison (control) group; no intervention)

    Not yet recruiting
    • Chronic Obstructive Pulmonary Disease (COPD)
    • (no location specified)
    Apr 26, 2022

    Peri-implant Mucositis Trial in Cairo (Er: YAG laser, plasma spray)

    Completed
    • Peri-implant Mucositis
    • Er: YAG laser
    • plasma spray
    • Cairo, Egypt
      Ain Shams University -Faculty of dentistry
    Apr 4, 2023

    Telemedicine, Elderly, Health Literacy Trial in Taoyuan (mobile health combined Multi-course Program)

    Completed
    • Telemedicine
    • +2 more
    • mobile health combined Multi-course Program
    • Taoyuan, Taiwan
      Landseed Intrenational Hospital
    Aug 1, 2022

    Esophageal Squamous Cell Carcinomas Trial in Beijing (SI-B001, Irinotecan)

    Recruiting
    • Esophageal Squamous Cell Carcinomas
    • Beijing, Beijing, China
      Beijing Cancer Hostital
    Mar 14, 2022

    Osteoarthritis Trial in United States (Bone Marrow Derived MSCs, Adipose-derived MSCs, Umbilical Cord Tissue (UCT) MSCs)

    Completed
    • Osteoarthritis
    • Bone Marrow Derived MSCs
    • +3 more
    • Gulf Breeze, Florida
    • +4 more
    Jul 5, 2022

    Preventive Medicine Trial (Interoceptive exposure)

    Recruiting
    • Preventive Medicine
    • Interoceptive exposure
    • Helsinki, Finland
      Orton Orthopaedic Hospital
    Sep 26, 2022

    Neoadjuvant Pembrolizumab in III-IVA Resectable Oral Squamous

    Recruiting
    • Oral Cavity Squamous Cell Carcinoma
    • Guangzhou, Guangdong, China
      Liuxiqiang
    Feb 1, 2023

    Diffuse Non-Hodgkin Lymphoma Trial in Zhengzhou, Tianjin (single dose of CNCT19)

    Active, not recruiting
    • Diffuse Non-Hodgkin Lymphoma
    • single dose of CNCT19
    • Zhengzhou, Henan, China
    • +1 more
    Feb 9, 2021

    Advanced NSCLC Trial (SHR-A1811 & Pyrotinib/SHR-A1811 & SHR-1316)

    Not yet recruiting
    • Advanced Non-small Cell Lung Cancer
    • SHR-A1811 & Pyrotinib/SHR-A1811 & SHR-1316
    • (no location specified)
    Jul 29, 2022

    Lung Cancer Trial in Worldwide (osimertinib)

    Active, not recruiting
    • Lung Cancer
    • Aarhus, Denmark
    • +9 more
    Apr 6, 2022

    Public Health Nursing Trial in Kayseri (Health education on healthy nutrition and regular physical activity based on the

    Completed
    • Public Health Nursing
    • Health education on healthy nutrition and regular physical activity based on the transtheoretic model
    • Kayseri, Küme Evler Mahallesi, Turkey
      Nuh Naci Yazgan University
    Jul 29, 2022

    Post-Transplant Lymphoproliferative Disorder, Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent DLBCL Trial in Seattle

    Not yet recruiting
    • Post-Transplant Lymphoproliferative Disorder
    • +10 more
    • Loncastuximab Tesirine
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jul 6, 2022

    Locally Advanced Thyroid Gland Anaplastic Carcinoma, Metastatic Thyroid Gland Anaplastic Carcinoma, Metastatic Thyroid Gland

    Not yet recruiting
    • Locally Advanced Thyroid Gland Anaplastic Carcinoma
    • +2 more
    • Chicago, Illinois
    • +1 more
    Jul 7, 2022

    Lymphoma Trial in United States (filgrastim, rituximab, carboplatin)

    Completed
    Has Results
    • Lymphoma
    • filgrastim
    • +8 more
    • Palo Alto, California
    • +103 more
    Oct 23, 2020

    Acute Myeloid Leukemia With KMT2A Rearrangement, Acute Myeloid Leukemia With NPM1 Mutation Trial (Biospecimen Collection, Bone

    Not yet recruiting
    • Acute Myeloid Leukemia With KMT2A Rearrangement
    • Acute Myeloid Leukemia With NPM1 Mutation
    • Biospecimen Collection
    • +7 more
    • (no location specified)
    Jun 1, 2023

    Diabetes Complications, Cardiovascular Diseases Trial in Portland (Mediterranean Diet)

    Recruiting
    • Diabetes Complications
    • Cardiovascular Diseases
    • Mediterranean Diet
    • Portland, Maine
      Maine Medical Center
    Jan 9, 2022

    Small Cell Lung Carcinoma Trial in Barcelona, Madrid (Lurbinectedin, Pembrolizumab)

    Recruiting
    • Small Cell Lung Carcinoma
    • Barcelona, Spain
    • +4 more
    Aug 12, 2022

    Isocitrate Dehydrogenase Gene Mutation Trial in Spain, United States (HMPL-306)

    Recruiting
    • Isocitrate Dehydrogenase Gene Mutation
    • Atlanta, Georgia
    • +6 more
    Feb 22, 2022

    no Condition Trial (N-acetylcysteine)

    Completed
    Has Results
    • no Condition
    • (no location specified)
    Oct 6, 2021

    Stress, Psychological, Caregivers Trial run by the National Institutes of Health Clinical Center (CC) (Stress reduction

    Completed
    • Stress, Psychological
    • Caregivers
    • Stress reduction intervention
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 13, 2023

    Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma Trial in Australia, United States (ABT-199)

    Completed
    • Chronic Lymphocytic Leukemia
    • Non-Hodgkin Lymphoma
    • Tucson, Arizona
    • +9 more
    Feb 10, 2022

    Carcinoma, Renal Cell Trial in Dallas (Fitbit Versa)

    Terminated
    • Carcinoma, Renal Cell
    • Fitbit Versa
    • Dallas, Texas
      University of Texas Southwestern Medical Center
    Feb 21, 2022